Novel diagnostic approaches and therapeutic management of mucormycosis: insights from a retrospective monocentric cohort study
This study underscores the challenges of managing mucormycosis in immunocompromised patients. The high mortality rate emphasizes the importance of early diagnosis, tailored antifungal therapy, and standardized treatment protocols to improve survival outcomes.
Authors
- Jo Caers (ORCID: https://orcid.org/0000-0002-3175-1195)
- Florence Rogister (ORCID: https://orcid.org/0000-0002-9483-6495)
- Alexandre Jadoul (ORCID: https://orcid.org/0000-0002-4461-6080)
- François Cousin (ORCID: https://orcid.org/0000-0003-4014-0297)
- A. Bouquegneau
- Adrien De Voeght (ORCID: https://orcid.org/0000-0003-3727-5190)
- Marie‐Pierre Hayette (ORCID: https://orcid.org/0000-0002-9025-6493)
- Bernard De Prijck
- Frédéric Frippiat
- Évelyne Willems
- Julien Guiot
- Frédéric Baron
- Othman Lemhamdi
Institutions
- University of Liège (BE)
- Laboratoire National de Référence (MA)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-02-04
- DOI
- https://doi.org/10.3389/fmed.2026.1715663
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00